Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calin Giurcaneanu

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Life (Basel, Switzerland)|October 26, 2024
Mechanisms of Resistance to Rituximab Used for the Treatment of Autoimmune Blistering DiseasesLiliana Gabriela Popa, Ioana Dumitras, Calin Giurcaneanu, et al.
Pharmaceutics|June 28, 2023
Antimicrobial Biomaterials for Chronic Wound CareAdrian Miron, Calin Giurcaneanu, Mara Madalina Mihai, et al.
Experimental and Therapeutic Medicine|November 26, 2021
Dysplastic nevus syndrome and pancreatic cancer: A case reportLiliana Gabriela Popa, Calin Giurcaneanu, Cornelia Nitipir, et al.
Medicina (Kaunas, Lithuania)|March 28, 2024
Perspectives on Psoriasiform Adverse Events from Immune Checkpoint Inhibitors: Lessons Learned from Our PracticeLiliana Gabriela Popa, Calin Giurcaneanu, Mariana Georgiana Portelli, et al.
Experimental and Therapeutic Medicine|August 9, 2020
Relationship between chemokines and T lymphocytes in the context of respiratory allergies (Review)Nicolae Ovidiu Berghi, Mihai Dumitru, Daniela Vrinceanu, et al.
Acta Dermatovenerologica Croatica : ADC|October 5, 2010
A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern EuropeTamás Palota, Jacek C Szepietowski, Jurai Pec, et al.
Current Topics in Medicinal Chemistry|April 17, 2015
Microbial biofilms: impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infectionsMara Madalina Mihai, Alina Maria Holban, Calin Giurcaneanu, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2016
Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled TrialMichael David, Dimitar Konstantinov Gospodinov, Nicola Gheorghe, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Life (Basel, Switzerland)|October 26, 2024
Mechanisms of Resistance to Rituximab Used for the Treatment of Autoimmune Blistering DiseasesLiliana Gabriela Popa, Ioana Dumitras, Calin Giurcaneanu, et al.
Pharmaceutics|June 28, 2023
Antimicrobial Biomaterials for Chronic Wound CareAdrian Miron, Calin Giurcaneanu, Mara Madalina Mihai, et al.
Experimental and Therapeutic Medicine|November 26, 2021
Dysplastic nevus syndrome and pancreatic cancer: A case reportLiliana Gabriela Popa, Calin Giurcaneanu, Cornelia Nitipir, et al.
Medicina (Kaunas, Lithuania)|March 28, 2024
Perspectives on Psoriasiform Adverse Events from Immune Checkpoint Inhibitors: Lessons Learned from Our PracticeLiliana Gabriela Popa, Calin Giurcaneanu, Mariana Georgiana Portelli, et al.
Experimental and Therapeutic Medicine|August 9, 2020
Relationship between chemokines and T lymphocytes in the context of respiratory allergies (Review)Nicolae Ovidiu Berghi, Mihai Dumitru, Daniela Vrinceanu, et al.
Acta Dermatovenerologica Croatica : ADC|October 5, 2010
A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern EuropeTamás Palota, Jacek C Szepietowski, Jurai Pec, et al.
Current Topics in Medicinal Chemistry|April 17, 2015
Microbial biofilms: impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infectionsMara Madalina Mihai, Alina Maria Holban, Calin Giurcaneanu, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2016
Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled TrialMichael David, Dimitar Konstantinov Gospodinov, Nicola Gheorghe, et al.
Pageof 3